Stroke recurrence and its prevention in patients with patent Foramen ovale

被引:36
|
作者
Harrer, JU
Wessels, T
Franke, A
Lucas, S
Berlit, R
Klötzsch, C
机构
[1] RWTH Aachen Univ Hosp, Dept Neurol, D-52074 Aachen, Germany
[2] RWTH Aachen Univ Hosp, Med Clin 1, Dept Cardiol, D-52074 Aachen, Germany
[3] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany
[4] Alfred Krupp Hosp, Dept Neurol, Essen, Germany
关键词
D O I
10.1017/S0317167100004674
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is unclear whether medical or invasive (surgical or catheter interventional) treatment is preferable to prevent recurrence of cerebral ischemia in patients with patent foramen ovale (PFO) as the Suspected cause of stroke and what the role of concomitant risk factors is in stroke recurrence. Methods: Over it period of ten years, 124 patients (mean age 5 1 15 years) with cryptogenic cerebral ischemia and PFO were included into the Study and prospectively followed over a mean of 52 32 months. Of these, 83 were treated medically, 34 underwent transcatheter closure, and seven had surgical closure of the foramen. Of the medically treated patients, 11 stopped medication during follow-up. Recurrent ischemic events and risk factors for recurrence were analyzed. Results: Annual stroke recurrence rates were generally low and comparable in catheter and medically treated patients, and in patients who had stopped medication (2.9%/2.1%/2.2%/ycar). Patients suffering from recurrence after transcatheter closure (n=2) both had residual shunts. No stroke recurrence was observed in the few surgically treated patients. An atrial septal aneurysm was not a predictor of recurrent or multiple strokes (p > 0.05, OR=0.31, and OR=0.74). Large shunts and a history of previous ischemic events were considerably more frequent in patients with recurrent strokes (p < 0.05, OR=5.0, and OR=4.4). Pulmonary embolism and case fatality rates were significantly higher in patients with stroke recurrence (p < 0.001, and p < 0.01). Conclusions: The absolute risk of recurrent cerebrovascular events in patients with PFO receiving medical or catheter interventional therapy is low. The small group of untreated patients had a comparably low rate of stroke recurrences. Previous ischemic events and shunt size were risk factors in this observational study. Given conflicting findings across multiple Studies, enrollment into a randomized controlled trial Would be the optimal choice.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
  • [41] Patent Foramen Ovale and Stroke
    Mono, M. -L.
    Nedeltchev, K.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2012, 80 (05) : 288 - 297
  • [42] Patent Foramen Ovale and Stroke
    Sun, Yee-Ping
    Homma, Shunichi
    CIRCULATION JOURNAL, 2016, 80 (08) : 1665 - 1673
  • [43] Patent foramen ovale and stroke
    Bruno Miranda
    Ana Catarina Fonseca
    José M. Ferro
    Journal of Neurology, 2018, 265 : 1943 - 1949
  • [44] Patent foramen ovale and stroke
    Meier, JM
    Delabays, A
    Girod, G
    Eeckhout, E
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2004, 97 (10): : 987 - 993
  • [45] How to prevent stroke recurrence in patients with patent foramen ovale: Anticoagulants, antiaggregants, foramen closure, or nothing?
    Nendaz, M
    Sarasin, FP
    Bogousslavsky, J
    EUROPEAN NEUROLOGY, 1997, 37 (04) : 199 - 204
  • [46] Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders
    Collado, Fareed Moses S.
    Poulin, Marie-France
    Murphy, Joshua J.
    Jneid, Hani
    Kavinsky, Clifford J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (12):
  • [47] Patent foramen ovale closure for secondary prevention of cryptogenic stroke
    Kolte, Dhaval
    Palacios, Igor F.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2021, 19 (03) : 211 - 220
  • [48] Editorial: Patent Foramen Ovale (PFO) Closure for Prevention of Stroke
    Kokkinidis, Damianos G.
    Katsanos, Aristeidis H.
    Giannakoulas, George
    Singh, Harsimran S.
    Turc, Guillaume
    Thijs, Vincent
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [49] Recurrent stroke in patients with cryptogenic stroke and patent foramen ovale
    Piriyawat, P
    Briggs, DE
    Chiu, D
    Kang, H
    Barasch, E
    Grotta, JC
    STROKE, 2002, 33 (01) : 382 - 382
  • [50] A Case Series : Patent Foramen Ovale Closure For Cryptogenic Stroke Prevention and Its Complication
    Mariska, E.
    Dwiputra, S.
    Michael
    Marliyanti, N.
    Sianipar, J.
    Handayani, F.
    Hidayatullah, M. S.
    Pratama, V.
    Permana, A. R.
    Pujowaskito, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F188 - F188